| JPM THEMATICS-GENETIC THERAPIES C2 (ACC) EUR (HEDGED) | RVI BIOTECNOLOGÍA | 38,31% | 29,86% | -28,30% | · |
| JPM THEMATICS-GENETIC THERAPIES C2 (ACC) GBP (HEDGED) | RVI BIOTECNOLOGÍA | 41,71% | 35,66% | -23,10% | · |
| JPM THEMATICS-GENETIC THERAPIES C2 (ACC) USD | RVI BIOTECNOLOGÍA | 40,45% | 25,67% | -22,21% | · |
| JPM THEMATICS-GENETIC THERAPIES C2 (DIST) CHF (HEDGED) | RVI BIOTECNOLOGÍA | 33,90% | 22,60% | -24,49% | · |
| JPM THEMATICS-GENETIC THERAPIES C2 (DIST) EUR (HEDGED) | RVI BIOTECNOLOGÍA | 37,82% | 28,67% | -29,05% | · |
| JPM THEMATICS-GENETIC THERAPIES C2 (DIST) GBP (HEDGED) | RVI BIOTECNOLOGÍA | 41,09% | 34,35% | -23,96% | · |
| JPM THEMATICS-GENETIC THERAPIES C2 (DIST) USD | RVI BIOTECNOLOGÍA | 39,92% | 24,49% | -23,06% | · |
| JPM THEMATICS-GENETIC THERAPIES C (ACC) EUR (HEDGED) | RVI BIOTECNOLOGÍA | 38,16% | 29,50% | -28,60% | · |
| JPM THEMATICS-GENETIC THERAPIES C (ACC) USD | RVI BIOTECNOLOGÍA | 40,29% | 25,33% | -22,55% | · |
| JPM THEMATICS-GENETIC THERAPIES C (DIST) GBP | RVI BIOTECNOLOGÍA | 40,17% | 24,03% | -23,43% | · |
